Amivantamab - HY-P9977
Nur noch %1 verfügbar
Catalog #
HY-P9977
Ab
362,00 €
Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P9977/Amivantamab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | Cancer-programmed cell death |
| Alternative Names | JNJ-61186372 |
| CAS | 2171511-58-1 |
| Storage | Store at -80°C for 2 years |
| MWT | N/A |
| Solubility | H2O |
| Clinical Information | Launched |
| Target | EGFR |
| Application: | Cancer-programmed cell death |
|---|